Dr Ross Campbell

Clinical Senior Lecturer in Heart Failure/Honorary Consultant (Cardiovascular & Metabolic Health)

Room c341, Level 3, BHF Glasgow Cardiovascular Research Facility

Biography

Dr Campbell completed his undergraduate degrees in Physiology (BSc 2004) and Medicine (MBChB 2006) at the University of Glasgow. He completed his Cardiology specialist training in the West of Scotland, during which time he undertook a PhD in heart failure research, supervised by professors John McMurray and Mark Petrie.

He initially worked as an NHS consultant cardiologist with specialist interest in cardiac imaging (cardiac MRI) and heart failure. He was the recipient of a Chief Science Officer NRS Career Researcher Fellowship in 2019. He joined the University of Glasgow as a Senior clinical lecturer and Honorary Consultant Cardiologist in 2022.

Dr Campbell is an honorary consultant cardiologist at both the Queen Elizabeth University Hospital and Golden Jubilee National Hospital, Glasgow.

Research interests

Research Theme: Cardiac Diseases

Dr Campbell’s research interests are in the use of novel diuretics and combinations of diuretics in patients with heart failure. He was the co-chief investigator of a combined novel drug – device trial (Phase I) using a novel preparation of furosemide delivered by a bespoke subcutaneous pump. He is also co-chief investigator on two multicentre randomised controlled trials.

His other research interests include:

The use of cardiac MRI and the assessment of remodelling, particularly in the context of randomised controlled clinical trials.
The use of artificial intelligence to accelerate clinical workflow, particularly in investigations of patients with suspected heart failure.

Research groups

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012

Number of items: 58.

2025

Bøgh-Sørensen, Sofie, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Claggett, Brian L, Lewis, Eldrin F, Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969, Lee, Matthew M.Y. ORCID: https://orcid.org/0000-0001-9213-2067, Lindner, Moritz, Biering-Sørensen, Tor, Solomon, Scott D. and Platz, Elke (2025) The intersection of obesity and acute heart failure: cardiac structure and function and congestion across BMI categories. European Heart Journal: Acute Cardiovascular Care, (doi: 10.1093/ehjacc/zuaf067) (PMID:40294203) (Early Online Publication)

Carberry, J. et al. (2025) Empagliflozin to prevent worsening of left ventricular volumes and systolic function after myocardial infarction (EMPRESS-MI). European Journal of Heart Failure, 27(3), pp. 566-576. (doi: 10.1002/ejhf.3560) (PMID:39675781) (PMCID:PMC11955320)

Osmanska, J. et al. (2025) Cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR-DM-HF). European Journal of Heart Failure, (doi: 10.1002/ejhf.3570) (PMID:39792133) (Early Online Publication)

Matsumoto, S. et al. (2025) Beta‐blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Journal of Heart Failure, 27(1), pp. 124-139. (doi: 10.1002/ejhf.3383) (PMID:39215677)

Osmanska, Joanna, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496, Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969, Lee, Matthew M.Y. ORCID: https://orcid.org/0000-0001-9213-2067, McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 and Campbell, Ross ORCID: https://orcid.org/0000-0002-0050-2129 (2025) Subcutaneous furosemide in heart failure: a systematic review. European Heart Journal: Cardiovascular Pharmacotherapy, 11(1), pp. 94-104. (doi: 10.1093/ehjcvp/pvae083) (PMID:39520561) (PMCID:PMC11805693)

2024

Yang, M. et al. (2024) Clinical characteristics and outcomes of patients aged 80 years and over with heart failure: Need for better treatment. European Journal of Heart Failure, (doi: 10.1002/ejhf.3417) (PMID:39169481) (Early Online Publication)

Cameron, A. et al. (2024) Natriuretic peptides to classify risk of atrial fibrillation detection after stroke: analysis of the BIOSIGNAL and PRECISE cohort studies. Neurology, 103(3), e209625. (doi: 10.1212/WNL.0000000000209625) (PMID:38950311) (PMCID:PMC11226326)

Carberry, J. et al. (2024) Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design. ESC Heart Failure, 11(4), pp. 2001-2012. (doi: 10.1002/ehf2.14830) (PMID:38715187) (PMCID:PMC11287338)

Kondo, T. et al. (2024) Low natriuretic peptide levels and outcomes in patients with heart failure and preserved ejection fraction. JACC: Heart Failure, 12(8), pp. 1442-1455. (doi: 10.1016/j.jchf.2024.04.027) (PMID:38904646)

Espersen, C. et al. (2024) Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure. International Journal of Cardiology, 406, 132036. (doi: 10.1016/j.ijcard.2024.132036) (PMID:38599465)

Kondo, T. et al. (2024) Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF. Journal of the American College of Cardiology, 83(20), pp. 1973-1986. (doi: 10.1016/j.jacc.2024.03.385) (PMID:38537918)

McDowell, K. et al. (2024) Prognostic models for mortality and morbidity in heart failure with preserved ejection fraction. JAMA Cardiology, 9(5), 457. (doi: 10.1001/jamacardio.2024.0284) (PMID:38536153)

Osmanska, Joanna, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129 (2024) Reply: subcutaneous furosemide patch: heart failure decongestion "from the comfort of your home". European Heart Journal: Cardiovascular Pharmacotherapy, 10(3), pp. 261-262. (doi: 10.1093/ehjcvp/pvae015) (PMID:38366161)

Lee, Matthew M.Y. ORCID: https://orcid.org/0000-0001-9213-2067, Kondo, Toru, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496, Sattar, Naveed ORCID: https://orcid.org/0000-0002-1604-2593, Solomon, Scott D., Vaduganathan, Muthiah, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2024) Effects of Renin-Angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomised controlled trials. European Heart Journal: Cardiovascular Pharmacotherapy, 10(1), pp. 68-80. (doi: 10.1093/ehjcvp/pvad067) (PMID:37740450) (PMCID:PMC10766905)

McDowell, Kirsty, Adamson, Carly, Jackson, Collette, Campbell, Ross ORCID: https://orcid.org/0000-0002-0050-2129, Welsh, Paul ORCID: https://orcid.org/0000-0002-7970-3643, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496, McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975, Jhund, Pardeep ORCID: https://orcid.org/0000-0003-4306-5317 and Herring, Neil (2024) Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes. European Journal of Heart Failure, 26(1), pp. 107-116. (doi: 10.1002/ejhf.3085) (PMID:37937329)

Osmanska, J. et al. (2024) A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies. European Heart Journal: Cardiovascular Pharmacotherapy, 10, pp. 35-44. (doi: 10.1093/ehjcvp/pvad073) (PMID:37804170) (PMCID:PMC10766906)

2023

Matsumoto, S. et al. (2023) Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction. European Journal of Heart Failure, 25(12), pp. 2202-2214. (doi: 10.1002/ejhf.3044) (PMID:37771260)

Matsumoto, Shingo, Kondo, Toru, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Swedberg, Karl, van Veldhuisen, Dirk J., Pocock, Stuart J., Pitt, Bertram, Zannad, Faiez and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2023) Underutilization of mineralocorticoid antagonists in patients with heart failure with reduced ejection fraction. Journal of the American College of Cardiology, 82(11), pp. 1080-1091. (doi: 10.1016/j.jacc.2023.06.021) (PMID:37642608)

Brennan, Alice C., Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129 and Lee, Matthew M.Y. ORCID: https://orcid.org/0000-0001-9213-2067 (2023) Influenza vaccination: a simple, safe, and effective treatment for patients with ischaemic heart disease and heart failure. European Journal of Heart Failure, 25(9), pp. 1693-1695. (doi: 10.1002/ejhf.2993) (PMID:37581224)

Yeoh, S. E. et al. (2023) Dapagliflozin versus metolazone in heart failure resistant to loop diuretics. European Heart Journal, 44(31), pp. 2966-2977. (doi: 10.1093/eurheartj/ehad341) (PMID:37210742)

Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969, Jackson, Alice M., Macartney, Mark, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496, Pfeffer, Marc A., McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 and Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317 (2023) Declining risk of heart failure hospitalization following first acute myocardial infarction in Scotland between 1991–2016. European Journal of Heart Failure, 25(8), pp. 1213-1224. (doi: 10.1002/ejhf.2965) (PMID:37401485)

McDowell, K. et al. (2023) Incremental prognostic value of biomarkers in PARADIGM-HF. European Journal of Heart Failure, 28(8), 1406-1414-1406-1414. (doi: 10.1002/ejhf.2887) (PMID:37191207)

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129 and Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969 (2023) Serum bicarbonate and congestion: a potential biomarker for identifying and guiding management in diuretic resistance? European Heart Journal, 44(22), pp. 2006-2008. (doi: 10.1093/eurheartj/ehad209) (PMID:37160825)

Graham, Fraser, Iaconelli, Antonio, Sonecki, Piotr, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Hunter, David, Cleland, John G.F. ORCID: https://orcid.org/0000-0002-1471-7016 and Pellicori, Pierpaolo ORCID: https://orcid.org/0000-0001-7175-0464 (2023) Defining heart failure based on imaging the heart and beyond. Cardiac Failure Review, 9, e11. (doi: 10.15420/cfr.2022.29) (PMID:37427007) (PMCID:PMC10326661)

Yeoh, S. E. et al. (2023) Endothelin-1, outcomes in patients with heart failure and reduced ejection fraction, and effects of dapagliflozin: findings from DAPA-HF. Circulation, 147(22), pp. 1670-1683. (doi: 10.1161/CIRCULATIONAHA.122.063327) (PMID:37039015) (PMCID:PMC10212584)

Lee, Matthew M.Y. ORCID: https://orcid.org/0000-0001-9213-2067, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Claggett, Brian L., Lewis, Eldrin F., Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969, Lindner, Moritz, Liu, Jiankang, Solomon, Scott D., McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 and Platz, Elke (2023) Health‐related quality of life in acute heart failure: association between patient‐reported symptoms and markers of congestion. European Journal of Heart Failure, 25(1), pp. 54-60. (doi: 10.1002/ejhf.2699) (PMID:36161429) (PMCID:PMC9892176)

2022

Welsh, P. et al. (2022) Reference ranges for NT-proBNP (N-terminal pro-B-type natriuretic peptide) and risk factors for higher NT-proBNP concentrations in a large general population cohort. Circulation: Heart Failure, 15(10), pp. 957-967. (doi: 10.1161/CIRCHEARTFAILURE.121.009427) (PMID:36098049) (PMCID:PMC9561238)

Lee, M. M.Y. et al. (2022) Effect of empagliflozin on kidney biochemical and imaging outcomes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 146(4), pp. 364-367. (doi: 10.1161/CIRCULATIONAHA.122.059851) (PMID:35877829)

Curtain, J. P. et al. (2022) Clinical outcomes related to background diuretic use and new diuretic initiation in patients with HFrEF. JACC: Heart Failure, 10(6), pp. 415-427. (doi: 10.1016/j.jchf.2022.01.020) (PMID:35654526)

2021

He, T. et al. (2021) Urinary peptides in heart failure: a link to molecular pathophysiology. European Journal of Heart Failure, 23(11), pp. 1875-1887. (doi: 10.1002/ejhf.2195) (PMID:33881206)

Lee, M. et al. (2021) Lung Ultrasound in Acute Heart Failure: Association Between Quality of Life, Symptoms and B-Lines. ESC Congress, 27-30 Aug 2021. (doi: 10.1093/eurheartj/ehab724.1043)

Rush, C. J. et al. (2021) Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. JAMA Cardiology, 6(10), pp. 1130-1143. (doi: 10.1001/jamacardio.2021.1825) (PMID:34160566) (PMCID:PMC8223134)

Docherty, K. F. et al. (2021) The effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction. Circulation, 144(3), pp. 199-209. (doi: 10.1161/CIRCULATIONAHA.121.054892) (PMID:33983794)

Espersen, C. et al. (2021) Sex differences in congestive markers in patients hospitalized for acute heart failure. ESC Heart Failure, 8(3), pp. 1784-1795. (doi: 10.1002/ehf2.13300) (PMID:33709520) (PMCID:PMC8120385)

Lee, M. M.Y. et al. (2021) Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF). Circulation, 143(6), pp. 516-525. (doi: 10.1161/CIRCULATIONAHA.120.052186) (PMID:33186500) (PMCID:PMC7864599)

Docherty, K. F. et al. (2021) Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling. ESC Heart Failure, 8(1), pp. 129-138. (doi: 10.1002/ehf2.13137) (PMID:33305513) (PMCID:PMC7835504)

2020

Campbell, R. T. et al. (2020) The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure. ESC Heart Failure, 7(4), pp. 1595-1604. (doi: 10.1002/ehf2.12708) (PMID:32383555) (PMCID:PMC7373887)

Israr, M. Z. et al. (2020) Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF. European Journal of Heart Failure, 22(8), pp. 1486-1490. (doi: 10.1002/ejhf.1951) (PMID:32666670)

2019

Dewan, P. et al. (2019) Sex-related differences in heart failure with preserved ejection fraction. Circulation: Heart Failure, 12(12), e006539. (doi: 10.1161/CIRCHEARTFAILURE.119.006539) (PMID:31813280)

Platz, E. et al. (2019) Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short- and long-term outcomes. JACC: Heart Failure, 7(10), pp. 849-858. (doi: 10.1016/j.jchf.2019.07.008) (PMID:31582107)

Lee, Matthew M.Y. ORCID: https://orcid.org/0000-0001-9213-2067, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Kelly, R., Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and Sonecki, P. (2019) Does “Scar” at Rest Echocardiography Predict Lack of Contractility Reserve at Dobutamine Stress Echocardiography. EuroEcho-Imaging 2018 Poster Session, Milan, Italy, Dec 2018. (doi: 10.1093/ehjci/jey266)

2018

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2018) Redefining heart failure phenotypes based on ejection fraction. European Journal of Heart Failure, 20(12), pp. 1634-1635. (doi: 10.1002/ejhf.1325) (PMID:30328651)

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2018) Talking to patients with heart failure about end of life. European Journal of Heart Failure, 20(12), pp. 1763-1765. (doi: 10.1002/ejhf.1321) (PMID:30295978) (PMCID:PMC6607510)

Rush, Christopher J., Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2018) Association is not causation: treatment effects cannot be estimated from observational data in heart failure. European Heart Journal, 39(37), pp. 3417-3438. (doi: 10.1093/eurheartj/ehy407) (PMID:30085087) (PMCID:PMC6166137)

Campbell, R. T. et al. (2018) Which patients with heart failure should receive specialist palliative care? European Journal of Heart Failure, 20(9), pp. 1338-1347. (doi: 10.1002/ejhf.1240) (PMID:29952090) (PMCID:PMC6607479)

2017

Platz, Elke, Merz, Allison A., Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Vazir, Ali, Campbell, Ross ORCID: https://orcid.org/0000-0002-0050-2129 and McMurray, John J. ORCID: https://orcid.org/0000-0002-6317-3975 (2017) Dynamic changes and prognostic value of pulmonary congestion by lung ultrasound in acute and chronic heart failure: a systematic review. European Journal of Heart Failure, 19(9), pp. 1154-1163. (doi: 10.1002/ejhf.839) (PMID:28557302)

Docherty, Kieran F. ORCID: https://orcid.org/0000-0002-5446-9969, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Jhund, Pardeep ORCID: https://orcid.org/0000-0003-4306-5317, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2017) How robust are clinical trials in heart failure? European Heart Journal, 38(5), pp. 338-345. (doi: 10.1093/eurheartj/ehw427) (PMID:27742808)

2016

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Willox, Gage P., Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Hawkins, Nathaniel M., Huang, Flora, Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J. V. ORCID: https://orcid.org/0000-0002-6317-3975 (2016) Reporting of lost to follow-up and treatment discontinuation in device and pharmacotherapy trials in chronic heart failure: a systematic review. Circulation: Heart Failure, 9(5), e002842. (doi: 10.1161/CIRCHEARTFAILURE.115.002842) (PMID:27162229)

2015

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Petrie, Colin J., Payne, Alex R. and McEntegart, Margaret (2015) Elderly woman presenting after a collapse. Annals of Emergency Medicine, 66(3), pp. 338-345. (doi: 10.1016/j.annemergmed.2014.10.017) (PMID:26304256)

Platz, Elke, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129 and McMurray, John ORCID: https://orcid.org/0000-0002-6317-3975 (2015) Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review. European Journal of Heart Failure, 17(9), pp. 906-916. (doi: 10.1002/ejhf.321) (PMID:26230356) (PMCID:PMC4725064)

Rush, Christopher J., Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Connolly, Eugene C., Preiss, David ORCID: https://orcid.org/0000-0003-3139-1836, Gardner, Roy S., Petrie, Mark C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2015) Falling cardiovascular mortality in heart failure with reduced ejection fraction and implications for clinical trials. JACC: Heart Failure, 3(8), pp. 603-614. (doi: 10.1016/j.jchf.2015.03.013) (PMID:26251086)

Preiss, D. et al. (2015) The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials. European Heart Journal, 36(24), pp. 1536-1546. (doi: 10.1093/eurheartj/ehv072) (PMID:25802390) (PMCID:PMC4769322)

Campbell, R. T. et al. (2015) Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Failure, 2(1), pp. 25-36. (doi: 10.1002/ehf2.12027) (PMID:27347426) (PMCID:PMC4864752)

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, Jhund, Pardeep S. ORCID: https://orcid.org/0000-0003-4306-5317, Dalzell, Jonathan R., Cannon, Jane, Mordi, Ify, Sonecki, Piotr and Tzemos, Nikolaos (2015) Diagnosis and resolution of loeffler endocarditis secondary to eosinphilic granulomatosis with polyangiitis demonstrated by cardiac magnetic resonance-t2 mapping. Circulation, 131(1), pp. 114-117. (doi: 10.1161/CIRCULATIONAHA.114.011291)

2014

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129, McKean, Andrew R. and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2014) Acute heart failure: have we got it all wrong? European Journal of Heart Failure, 16(12), pp. 1263-1267. (doi: 10.1002/ejhf.197)

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2014) Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Failure Clinics, 10(3), pp. 481-501. (doi: 10.1016/j.hfc.2014.04.009)

2013

Campbell, Ross T. ORCID: https://orcid.org/0000-0002-0050-2129 and McMurray, John J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2013) Reply: Diagnosis of Heart Failure With Preserved Ejection Fraction: Still a Challenge, Journal of the American College of Cardiology, Volume 61, Issue 16, 23 April 2013, Pages 1748-1749. Journal of the American College of Cardiology, 61(16), p. 1749. (doi: 10.1016/j.jacc.2013.01.012)

2012

Campbell, R.T. ORCID: https://orcid.org/0000-0002-0050-2129, Jhund, P.S. ORCID: https://orcid.org/0000-0003-4306-5317, Castagno, D., Hawkins, N.M., Petrie, M.C. ORCID: https://orcid.org/0000-0002-6333-9496 and McMurray, J.J.V. ORCID: https://orcid.org/0000-0002-6317-3975 (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? Journal of the American College of Cardiology, 60(23), pp. 2349-2356. (doi: 10.1016/j.jacc.2012.04.064)

This list was generated on Sun Jun 15 13:26:02 2025 BST.

Jump to: Articles | Conference or Workshop Item